Taking Antidepressants During Pregnancy Not Associated With Neonatal Problems At 2-4 Weeks

Taking Antidepressants During Pregnancy Not Associated With Neonatal Problems At 2-4 Weeks

ArticlePress release
Behavioral & Mental Health
Kids' Zone
+2
Contributed byKrish Tangella MD, MBAJun 13, 2017

Babies exposed to an antidepressant or a mood disorder during fetal life did not have any more signs of irritability, difficulty feeding, sleep disturbances and respiratory problems two to four weeks after birth than babies who were not exposed. Instead, the major factor associated with newborn problems was preterm birth, according to a new Northwestern Medicine study.

Similar studies have assessed babies earlier -- less than two weeks -- but this study looked at babies two to four weeks after birth. The additional time led the scientists to determine preterm birth as the main cause of these neonatal signs of agitation, excessive crying, rigidity, tremors and restlessness, typically called Neonatal Discontinuation Syndrome (NDS).

Many women are concerned about taking antidepressants because they've heard the presence of these neonatal signs are more common in babies exposed to antidepressants.

"I believe that is true directly after birth, but this study shows those signs appear to be short-lived," said senior author Dr. Katherine Wisner, the Norman and Helen Asher Professor of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology at Northwestern University Feinberg School of Medicine and a Northwestern Medicine psychiatrist. "At two to four weeks postpartum, the signs women were reporting to us were more associated with preterm birth rather than whether their babies were exposed."

The additional two weeks also gave parents time to adjust to their newborns at home to better assess if their infants' behaviors were of concern to them. They could look for signs that couldn't be readily assessed during typical, 10- to 15-minute doctor examinations, such as length of sleep post-feeding, fever, projectile vomiting and stool characteristics.

The study was published May 24 in the Journal of Clinical Psychiatry.

"Most pregnant women are naturally going to worry more about their baby's health than their own and might forego taking an antidepressant to avoid these neonatal signs," said first author Amy Yang. "But with the information from this study, they can be reassured that the baby's behavior at two to four weeks after birth is not likely due to exposure to medication or depression."

The researchers studied 214 mothers who were divided into three groups: Women with a mood disorder who were not taking any antidepressants; women with a mood disorder who were taking a serotonin reuptake inhibitor (SRI) antidepressant; women who did not have a mood disorder and were not taking an SRI antidepressant (comparison group).

They evaluated the babies for signs on the Finnegan Scale, which lists 21 symptoms that are most frequently observed in infants who have been exposed to illicit or prescription drugs. The rates of sign presence in the SRI, mood disorder and comparison groups were similar at 34.1 percent, 35.1 percent and 30.4 percent, respectively.

"We observed a significant relationship between Finnegan signs and preterm birth independent of SRI antidepressant exposure," said Yang, biostatistician for Northwestern's Asher Center for the Study and Treatment of Depressive Disorders. "Studies of NDS should consider the contribution of preterm birth to infant behavior."


Materials provided by Northwestern UniversityNote: Content may be edited for style and length.

Disclaimer: DoveMed is not responsible for the accuracy of the adapted version of news releases posted to DoveMed by contributing universities and institutions.

Primary Resource:

Yang, A., Ciolino, J. D., Pinheiro, E., Rasmussen-Torvik, L. J., Sit, D. K., & Wisner, K. L. (2017). Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates. The Journal of clinical psychiatry78(5), 605. DOI: 10.4088/JCP.16m11044

Was this article helpful

On the Article

Krish Tangella MD, MBA picture
Approved by

Krish Tangella MD, MBA

Pathology, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!